✦ LIBER ✦

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

✍ Scribed by van Zandwijk, N; Mathy, A; Boerrigter, L; Ruijter, H; Tielen, I; de Jong, D; Baas, P; Burgers, S; Nederlof, P

Book ID: 118038955
Publisher: Oxford University Press
Year: 2007
Tongue: English
Weight: 107 KB
Volume: 18
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdl323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Which tyrosine kinase inhibitor should b

Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?

✍ Alfredo Tartarone,Rosa Lerose,Chiara Lazzari,Vanesa Gregorc… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 284 KB

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

New CT response criteria in non-small ce

New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy

✍ Lee, Ho Yun; Lee, Kyung Soo; Ahn, Myung-Ju; Hwang, Hye Sun; Lee, Ju Won; Park, K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 819 KB

Volumetric tumor growth in advanced non-

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Do We Really Need Another Epidermal Grow

Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non-Small-Cell Lung Cancer and EGFR Mutations?

✍ Haspinger, E. R.; Garassino, M. C.; Torri, V.; Cinquini, M.; De Braud, F.; Gelso 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 78 KB

Uncommon Epidermal Growth Factor Recepto

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance

✍ Massarelli, Erminia; Johnson, Faye M.; Erickson, Heidi S.; Wistuba, Ignacio I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 478 KB